Post Profile






Partners in Huge Cannabis Therapy Operation Planned for Australia Apply for Licenses

Two companies that plan a huge cannabis-growing and research facility in Australia have applied for licenses to run the operations, whose products could benefit multiple sclerosis patients. MYM Nutraceuticals and PUF Ventures Australia asked the Australian Office of Drug Control for both medical cannabis and cannabis research licenses. The applications come at a time when medical cannabis use is increasing.
read more

share

Related Posts


Medical News Today: Multiple sclerosis symptoms improved with fruit and veg

Health : Medical News Today

A diet rich in fruits, vegetables, and whole grains may significantly improve symptoms for people with multiple sclerosis, researchers report.

Pilot Study of myMS App, Created to Aid Patients and Research, Starting in US

Diseases & Conditions / Multiple Sclerosis : Multiple Sclerosis News Today

A clinical trial of a smartphone app that helps multiple sclerosis (MS) understand and manage their disease — and to aid and speed research — is now recruiting people nationwide. Claimed to be the first of its kind, the app, called ...

Key Ingredient in RegeneRx’s RGN-352 Treatment for MS Wins Australian Patent

Diseases & Conditions / Multiple Sclerosis : Multiple Sclerosis News Today

Australia has granted a patent to RegeneRx Biopharmaceuticals for an active ingredient in a therapy that could benefit multiple sclerosis (MS) patients. The patent is for Thymosin beta 4 (T?4), the driving force in the company’s RGN...

Tecfidera Improves MS Patients’ Work Productivity, Compared with Other Therapies, Study Shows

Diseases & Conditions / Multiple Sclerosis : Multiple Sclerosis News Today

Multiple sclerosis patients taking Tecfidera, or dimethyl fumarate, were more productive at work than those on Copaxone or beta-interferon therapies, according to a study. Tecfidera also increased patients’ quality of life, research...

IQuity Says $1 Million NIH Grant Will Fund Company’s Research on RNA-based Therapies that Help MS Patients

Diseases & Conditions / Multiple Sclerosis : Multiple Sclerosis News Today

The National Institutes of Health (NIH) has awarded a $1 million grant to IQuity, a Nashville-based company looking into novel RNA targets that ultimately benefit patients with multiple sclerosis (MS) and other autoimmune disorders....

Comments


Copyright © 2016 Regator, LLC